Biomarker/test | Early | Late | No control | Control | |
---|---|---|---|---|---|
E vs L | Covariate | E vs L | |||
p | p | p | |||
APOE e4, proportion | 1.1 ± 0.8 | 0.9 ± 0.8 | ns | * | ** |
CSF Aβ42, pgm/mL | 584 ± 235 | 458 ± 177 | ** | ** | ns |
CSF total-tau, pgm/mL | 476 ± 265 | 521 ± 241 | ns | * | ns |
CSF p-tau, pgm/mL | 74 ± 27 | 79 ± 31 | ns | ns | ns |
PET neocortical PiB | 1.42 ± 0.23 | 1.58 ± 0.24 | *** | *** | ns |
PET FDG index | 1.52 ± 0.39 | 1.32 ± 0.29 | * | *** | ns |
Similarities, z-score | − 0.5 ± 1.2 | − 1.2 ± 1.6 | ** | *** | ns |
Block Design, z-score | − 0.9 ± 0.9 | − 1.7 ± 0.8 | *** | *** | ns |
RAVL, z-score | − 1.2 ± 1.4 | − 2.3 ± 1.3 | *** | *** | ns |
RO retention, z-score | − 0.7 ± 1.1 | − 1.3 ± 0.8 | ** | *** | ns |
Digit Symbol, z-score | − 1.1 ± 1.1 | − 2.2 ± 1.2 | *** | *** | ns |